Search results for: "johnson johnson" (218 records) Regulatory Johnson & Johnson seeks approval for subcutaneous formulation of Rybrevant to treat EGFR-mutated NSCLC The submission to the EMA is supported by data from the Phase III PALOMA-3 study, which showed the non-inferiority of subcutaneous Rybrevant to intravenous administration Digital Closed Loop Medicine appoints Paul Johnson as Non-Executive Director Paul will work with the company to drive forward its commercialisation strategy for its portfolio of precision care solutions Research & Development Johnson & Johnson's TAR-200 monotherapy exhibits >80% CR rate in bladder cancer TAR-200 provides durable CRs in patients with Bacillus Calmette-Guérin (BCG)-unresponsive high-risk non-muscle invasive bladder cancer (BCG-HR-NMIBC) Regulatory Johnson & Johnson submits regulatory application for Tremfya to the European Medicines Agency The submission included data from the Phase 3 QUASAR programme in ulcerative colitis and the Phase 3 GALAXI programme in Crohn’s disease, which each achieved their primary... Marketing Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK Manufacturing Kindeva Drug Delivery appoints Denis Johnson as Chief Operating Officer Denis will be responsible for optimising global operations for the company Hi Tech Manufacturing Johnson Matthey agrees to sell Medical Device Components business The business has been sold to Montagu Private Equity for USD $700m Sustainability Johnson Matthey partners with Basecamp Research to accelerate the adoption of biocatalysis solutions Expanding biocatalyst solutions will reduce energy use and waste in pharmaceutical and agrochemical industries Regulatory FDA grants approval for Johnson & Johnson's antibody for treatment of myeloma Johnson & Johnson have received accelerated approval of TALVEY, a first-in-class bispecific antibody. TALVEY is a bispecific T-cell engaging antibody that binds to the CD3... Manufacturing First-line treatment for patients with metastatic castration-resistant prostate cancer A company has submitted an NDA for niraparib in combination with abiraterone acetate, in the form of a dual-action tablet (DAT) Manufacturing JM Health rebrands as Veranova following sale to Altaris Capital Partners Veranova, formerly known as Johnson Matthey Health, has launched as an independent company following the acquisition by Altaris Capital Partners, LLC from Johnson Matthey PLC Research & Development F-star Therapeutics announces license agreement with Janssen The agreement grants Janssen an exclusive license to research, develop, and commercialise bispecific antibodies directed to its therapeutic targets using F-star’s proprietary... Finance Tekni-Plex acquires Johnson Plastic Group The acquisition expands Tekni-Plex Healthcare’s medical device capabilities and gives it a presence in Mexico Research & Development BioMed X and Janssen R&D announce two research groups The groups will explore research related to autoimmunity and drug delivery Ingredients Therapeutic: nipocalimab for myasthenia gravis The chronic autoimmune disease, myasthenia gravis, affects the skeletal muscles responsible for eye movements, breathing and motion Research & Development BioMed X begins research project for oral therapeutics delivery The collaboration with Janssen Research and Development was facilitated by Johnson & Johnson Innovation Previous12 (current)34567…14Next
